Clinical Trials Browser

Phase 1/2 × OTHER × Hematopoietic and Lymphoid System Neoplasm × Clear all

NCT04022239 2026-01-12

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

Phase 1/2 Recruiting

Hematopoietic and Lymphoid System Neoplasm